EP300 and lung carcinoma: Recent studies show that the inhibition of p300/CBP by several small molecule inhibitors decreases cell proliferation and improves sensitivity to chemotherapy in lung cancer cells, suggesting a relevant role of p300 and CBP in this tumor histotype [20–24].